Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Molecular biology of bone metastasis Kingsley LA; Fournier PG; Chirgwin JM; Guise TAMol Cancer Ther 2007[Oct]; 6 (10): 2609-17Metastasis is a final stage of tumor progression. Breast and prostate cancer cells preferentially metastasize to bone, wherein they cause incurable osteolytic and osteoblastic lesions. The bone matrix is rich in factors, such as transforming growth factor-beta and insulin-like growth factors, which are released into the tumor microenvironment by osteolysis. These factors stimulate the growth of tumor cells and alter their phenotype, thus promoting a vicious cycle of metastasis and bone pathology. Physical factors within the bone microenvironment, including low oxygen levels, acidic pH, and high extracellular calcium concentrations, may also enhance tumor growth. These elements of the microenvironment are potential targets for chemotherapeutic intervention to halt tumor growth and suppress bone metastasis.|Bone Neoplasms/metabolism/*secondary[MESH]|Breast Neoplasms/*pathology[MESH]|Female[MESH]|Humans[MESH]|Hydrogen-Ion Concentration[MESH]|Male[MESH]|Molecular Biology[MESH]|Osteolysis[MESH]|Prostatic Neoplasms/*pathology[MESH]|Somatomedins/physiology[MESH]|Transforming Growth Factor beta/physiology[MESH] |